X

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Manager/Senior Manager - Quality Assurance, Good Clinical Practice

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A bachelor's degree in a scientific or health field and at least 4 years of GxP quality assurance experience for Manager level or 7 years for Senior Manager level, including at least 4 years of GCP quality assurance supporting both development and commercial programs in the pharmaceutical or biotechnology industry.
  • At least 3 years in a quality lead role in a pharmaceutical or biotechnology environment.
  • Extensive knowledge of GCP regulations, guidelines, current industry trends, standards, and methodologies.
  • Sound knowledge of GLP regulations, guidelines, current industry trends, standards, and methodologies.
  • Experience in early-phase clinical development before Phase 3.
  • Experience conducting audits, adapting issues into effective corrective and preventive actions, and evaluating trends to mitigate risks.
  • Ability to prioritize and manage multiple complex projects in parallel and achieve critical milestones and deliverables within established timelines and budgets.
  • Strategic thinking, organizational skills, and ability to drive project teams forward while doing the work required to achieve goals.
  • Ability to communicate clearly, concisely, and consistently, verbally and in writing, with internal and external stakeholders.
  • Ability to work independently and collaboratively as part of a multidisciplinary team.

Responsibilities

  • Serve as the quality representative for assigned early-phase clinical programs, including developing and maintaining Quality Plans, facilitating study quality risk assessments, and overseeing Critical to Quality Factors and Quality Tolerance Limits.
  • Support quality oversight of GLP programs, including audit program activities, and collaborate with Quality Systems to develop the annual audit plan.
  • Provide GLP/GCP compliance interpretation, consultation, training, root cause analysis, and other support to maintain and improve the quality of the Company’s R&D programs, safeguard study participants’ safety and rights, and ensure the quality, integrity, and credibility of generated data.
  • Identify and appropriately escalate critical quality issues to QA Management.
  • Assist with preparation for and support regulatory inspections conducted remotely and onsite at Company offices, clinical trial sites, and contract service provider facilities, as needed.
  • Communicate effectively and inclusively across functions, collaborating with internal and external stakeholders on quality principles and regulatory requirements while maintaining independence.
  • Support short- and long-term objectives for the GLP/GCP functions in accordance with Company and Quality strategies.
  • Act in accordance with Company policies, including the Code of Business Conduct and Ethics, and ensure policies are understood and followed by direct reports, if any.
  • Perform other duties as assigned.

Desired Qualifications

  • Experience interacting with regulatory inspectorates such as the FDA, Health Canada, EMA, and MHRA.

About the Company

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for neurological disorders, especially epilepsy, through research and collaboration with partners and licensors to support eventual product commercialization. Its drug candidates are designed to treat CNS and genetic contributors to disease, with examples like XEN007 reaching Phase 2 proof-of-concept in treatment-resistant pediatric childhood absence epilepsy, illustrating targeted therapeutic development. The company concentrates on genetics-informed neurology and maintains a pipeline funded in part by partnerships and licensing, setting it apart from broader pharma players. Its goal is to discover, develop, and bring therapies to patients to address unmet needs in neurology and epilepsy.

Company size
201-500
Company stage
IPO
Headquarters
Burnaby, Canada
Founded
1996

Recently Posted Jobs

Explore more opportunities at Xenon Pharmaceuticals

See more jobs